This episode delves into key regulatory topics affecting the European Union, including the gradual reduction of the Asset Purchase Programme by the European Central Bank, recent warnings on the off-label use of Fosphenytoin in children, and a pivotal court ruling on the revocation of EU freedom of movement rights.

The European Commission approved the joint control acquisition of Rayner Surgical Group by GBL and CVC, confirming compliance with EU merger regulations and the internal market framework. This cross-border merger highlights ongoing regulatory oversight in manufacturing and investment sectors.

In environmental policy, the EU, Brazil, and China launched an open coalition to enhance the integrity and effectiveness of carbon markets. This initiative supports the Paris Agreement by promoting high-quality carbon credits and improving carbon pricing mechanisms, advancing the Emissions Trading System’s capabilities.

Additionally, the Verwaltungsgericht Berlin ruled against unlawful revocation of EU freedom of movement rights, emphasizing strict legal standards for public order threats and reinforcing individual rights.

For more information, visit the Carver Agents website.

Articles mentioned:

1. GBL / CVC / RAYNER
2. EU, Brazil and China launch open coalition to boost integrity and effectiveness of carbon markets
3. Direct Healthcare Professional Communication (DHCP) on Fosphenytoin Desitin 75 mg/ml solution for infusion/injection (fosphenytoin disodium): risk of medication errors and off-label use in children under 5 years of age
4. Direct Healthcare Professional Communication (DHCP) on Fosphenytoin Desitin 75 mg/ml solution for infusion/injection (fosphenytoin disodium): risk of medication errors and off-label use in children under 5 years of age
5. See All Closed Consultations
6. Irin verliert EU-Freizügigkeit nicht (Nr. 24/2026)
7. OAI / SBG / SB OAI JV
8. Riscontro sul contributo fornito dal Parlamento europeo nel quadro della sua risoluzione sul Rapporto annuale 2024 della BCE
9. Digital assets, payment efficiency and monetary policy
10. Minutes - Executive Steering Group on Shortages of Medical Devices (MDSSG) (23 March 2026)